Evidence map›Paper›PMID 2211834›Full record

ArticleThe Journal of cell biology1990

Echistatin is a potent inhibitor of bone resorption in culture.

M Sato, M K Sardana, W A Grasser, V M Garsky, J M Murray, R J Gould

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 1990. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 200 citations in OpenAlex.

  1. Article
  2. Review
  3. Snake venom disintegrins update: insights about new findings.The journal of venomous animals and toxins including tropical diseases · 2023
    Review
  4. Cancer biotherapy & radiopharmaceuticals · 2018
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Trabecular bone deterioration in col9a1+/- mice associated with enlarged osteoclasts adhered to collagen IX-deficient bone.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2008
    Article
  11. Involvement of alpha(v)beta3 integrins in osteoclast function.Journal of bone and mineral metabolism · 2007
    Review
  12. Molecular regulation of osteoclast activity.Reviews in endocrine & metabolic disorders · 2006
    Review
  13. Article
  14. The role of alphav integrins during angiogenesis.Molecular medicine (Cambridge, Mass.) · 1998
    Review
  15. Article
  16. Article
  17. Development of a new method for obtaining osteoclasts from endosteal surfaces.In vitro cellular & developmental biology. Animal · 1996
    Article
  18. Molecular aspects of osteoclast function.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 1996
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

M SatoDepartment of Bone Biology, Merck Sharp & Dohme Research Laboratories, West Point, Pennsylvania 19486.
M K Sardana
W A Grasser
V M Garsky
J M Murray
R J Gould
United States Military Academy · US

Funding

SYSTEM FOR QUANTITATIVE 3D CONFOCAL LIGHT MICROSCOPYS10RR005008 · NCRR · UNIVERSITY OF PENNSYLVANIA · PI MURRAY, JOHN M · 1989 to 1989
–
NCRR NIH HHS S10-RR05008
6 · The paper itself

Abstract

The venom protein, s-echistatin, originally derived from the saw-scaled viper Echis carinatus, was found to be a potent inhibitor of bone resorption by isolated osteoclasts. This Arg24-Gly25-Asp26-(RGD)-containing protein inhibited the excavation of bone slices by rat osteoclasts (IC50 = 0.1 nM). It also inhibited the release of [3H]proline from labeled bone particles by chicken osteoclasts (IC50 = 100 nM). By comparison, the tetrapeptide Arg-Gly-Asp-Ser (RGDS) inhibited resorption by rat or chicken osteoclasts with an IC50 of 0.1 mM while ala24-echistatin was inactive. Video microscopy showed that rat osteoclast attachment to substrate was more sensitive to s-echistatin than was the attachment of mononuclear cells or chicken osteoclasts. The difference in sensitivity of rat and chicken osteoclasts to s-echistatin may be due to differences between receptors on rat and chicken osteoclasts for s-echistatin. Antibody localization of echistatin on these cells showed much greater echistatin binding to rat osteoclasts than to chicken osteoclasts. Laser scanning confocal microscopy after immunohistochemical staining showed that s-echistatin binds to osteoclasts, that s-echistatin receptors are most abundant at the osteoclast/glass interface, and that s-echistatin colocalizes with vinculin. Confocal interference reflection microscopy of osteoclasts incubated with s-echistatin, demonstrated colocalization of s-echistatin with the outer edges of clusters of grey contacts at the tips of some lamellipodia. Identification of the echistatin receptor as an integrin was confirmed by colocalization of echistatin fluorescence with staining for an alpha-like subunit. Attachment of bone particles labeled with [3H]proline to chicken osteoclasts confirmed that the mechanism of action of echistatin was to inhibit osteoclast binding to bone presumably by disrupting adhesion structures. These data demonstrate that osteoclasts bind to bone via an RGD-sequence as an obligatory step in bone resorption, that this RGD-binding integrin is at adhesion structures, and that it colocalizes with vinculin and has an alpha-like subunit.

Indexed as

Bone ResorptionAmino Acid SequenceAnimalsCell AdhesionChickensIntegrinsIntercellular Signaling Peptides and ProteinsIn Vitro TechniquesMolecular Sequence DataOligopeptidesOsteoclastsPeptidesRatsViper Venomsarginyl-glycyl-aspartyl-serineechistatinIntegrinsIntercellular Signaling Peptides and ProteinsOligopeptidesPeptidesViper Venoms

Identifiers

PMID2211834
PMCPMC2116239
OpenAlexW2022811527

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.